[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed by Arteris details insider trading activity by Nicholas Hawkins. The filing indicates a proposed sale of 11,276 shares of common stock with an aggregate market value of $101,709.52 through Morgan Stanley Smith Barney LLC, planned for execution on June 25, 2025 on NASDAQ.

Key transaction details:

• Original acquisition: 11,276 shares via stock options on December 19, 2019
• Current outstanding shares: 41,977,728
• Recent trading history: Hawkins executed multiple sales in past 3 months totaling 26,496 shares for approximately $193,623
• Most transactions were conducted under a 10b5-1 trading plan

This Form 144 represents a standard insider sale notification, with the seller affirming no knowledge of undisclosed material adverse information regarding Arteris's operations.

Positive

• None.

Negative

• Insider Nicholas Hawkins has sold a total of 26,496 shares over the past 3 months through both planned and discretionary sales, with cumulative proceeds of $193,624, indicating consistent selling pressure from management

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11276	101709.52	41977728	06/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/19/2019	Previously Exercised Stock Options	Issuer			11276	12/19/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/09/2025	3770	30405.45
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/05/2025	721	5521.06
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/04/2025	1730	13877.18
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/02/2025	438	3374.05
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	05/08/2025	11000	82946.05
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	04/04/2025	4949	29822.67
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	04/02/2025	3888	27677.12

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares of AIP stock is being sold according to the June 2025 Form 144?

According to the Form 144 filing, 11,276 shares of Arteris Inc (AIP) common stock are proposed to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $101,709.52.

Who is selling AIP shares in this Form 144 filing?

Nicholas Hawkins is selling AIP shares through a 10b5-1 Sales Plan. The shares were originally acquired on December 19, 2019 through previously exercised stock options from the issuer.

What is the total value of AIP shares Nicholas Hawkins sold in the past 3 months?

In the three months prior to this filing, Nicholas Hawkins sold a total of 26,496 shares of AIP common stock through various transactions, generating total gross proceeds of approximately $193,623.58.

What is the current number of outstanding shares of AIP stock?

According to the Form 144 filing, Arteris Inc (AIP) has 41,977,728 shares outstanding as of the filing date.

When is the approximate date of sale for the AIP shares in this Form 144?

The Form 144 indicates that the approximate date of sale for the 11,276 shares is June 25, 2025, to be executed on the NASDAQ exchange.